Apollon Formularies (AQSE:APOL) Interest Coverage : No Debt ⁽¹⁾ (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Apollon Formularies's Operating Income for the six months ended in Jun. 2023 was £-0.40 Mil. Apollon Formularies's Interest Expense for the six months ended in Jun. 2023 was £0.00 Mil. Apollon Formularies has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Apollon Formularies PLC has no debt.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Apollon Formularies's Interest Coverage or its related term are showing as below:

AQSE:APOL' s Interest Coverage Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: No Debt
Current: No Debt

AQSE:APOL's Interest Coverage is ranked better than
99.41% of 683 companies
in the Drug Manufacturers industry
Industry Median: 12.25 vs AQSE:APOL: No Debt

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Apollon Formularies Interest Coverage Historical Data

The historical data trend for Apollon Formularies's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Apollon Formularies Interest Coverage Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Coverage

Get a 7-Day Free Trial

No Debt

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Interest Coverage	Get a 7-Day Free Trial											No Debt	-	No Debt	No Debt	No Debt

Competitive Comparison of Apollon Formularies's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Interest Coverage falls into.

Apollon Formularies Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Apollon Formularies's Interest Coverage for the fiscal year that ended in Dec. 2021 is calculated as

Here, for the fiscal year that ended in Dec. 2021, Apollon Formularies's Interest Expense was £-0.00 Mil. Its Operating Income was £-0.76 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.00 Mil.

Apollon Formularies did not have earnings to cover the interest expense.

Apollon Formularies's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Here, for the six months ended in Jun. 2023, Apollon Formularies's Interest Expense was £0.00 Mil. Its Operating Income was £-0.40 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.00 Mil.

Apollon Formularies had no debt ⁽¹⁾.

The higher the ratio, the stronger the company's Financial Strength is.

Apollon Formularies (AQSE:APOL) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Apollon Formularies Interest Coverage Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.